Skip to main content
SpringerLink
Log in

Is Laparoscopic Resection Adequate in Patients with Neuroendocrine Pancreatic Tumors?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Since the first reports with laparoscopic resection of islet cell tumors in 1996, the experience worldwide is still limited, with only short-term outcomes available. Some have suggested that a malignant tumor is a contraindication to laparoscopic resection.

Aim The aim of this study was to evaluate the feasibility, safety, and long-term outcome of the laparoscopic approach in patients with functioning, nonfunctioning, or overt malignant pancreatic neuroendocrine tumor (PNT). To our knowledge this is the largest single-institution series on this subject to date.

Patients and methods A total of 49 consecutive patients (43 women, 6 men; mean age 58 years, range 22–83 years) underwent laparoscopic pancreatic surgery (LPS) from April 1998 to June 2007. Preoperative localization was done by computed tomography, magnetic resonance imaging, endoscopic ultrasonography, and Octreoscan imaging. Other than 9 PNTs localized in the head of the pancreas, all tumors were located in the left pancreas. Malignancy was diagnosed based on the presence of lymph nodes or liver metastasis. There were 33 patients with functioning tumors: 4 with gastrinomas (mean size 1.2 cm), 1 with a glucagonoma (4 cm), 3 with vipomas (3.2 cm), 2 with carcinoids (5.2 cm), 20 with sporadic insulinomas (1.4 cm), 2 with insulinoma/multiple endocrine neoplasia type 1 (MEN-1) (4.4 cm), and 1 with a malignant insulinoma (13 cm). Sixteen patients had a nonfunctioning tumor (mean size 5 cm). The following techniques were performed: laparoscopic spleen-preserving distal pancreatectomy (Lap SPDP), laparoscopic distal pancreatectomy with splenectomy (Lap SxDP) and laparoscopic enucleation (Lap En)/laparoscopic excision (Lap E). Lymph node dissection was performed when malignancy was suspected (Strasberg´s technique). Evaluation criteria included operative and postoperative factors, pathologic data including R0 or R1 resection (the pancreatic transection margin and all transection margins on the specimen were inked). Long-term outcomes were analyzed by tumor recurrence and patient survival.

Results Four cases (8.2%) were converted to open surgery. Overall, Lap SPDP, Lap SxDP, and Lap En/Lap E were performed in 15 (33.3%), 8 (17.8%), and 22 (48.9%) patients, respectively. The operative time and blood loss was significantly lower in the Lap En group compared with the other laparoscopic techniques. The group of patients with malignant tumors undergoing Lap SxDP had a longer operating time and greater blood loss compared with the other distal pancreatectomy (Lap DP) techniques. Overall, the postoperative complications were significantly higher in the Lap En group (42.8%) than in the Lap DP (Lap SPDP + Lap SxDP) group (22%). These complications were mainly pancreatic fistula: 8.7% after Lap DP and 38% after Lap En. The overall morbidity was significantly higher after Lap SPDP (26.7%) than after Lap SxDP (12.5%) owing to the occurrence of splenic complications in the Lap SPDP group without splenic vessel preservation two of seven (28.5%). The means and ranges of hospital stay after Lap SPDP, Lap SxDP, and Lap En/Lap E were 5.9 (5–14), 7.5 (5–12), and 5.5 (5–7) days, respectively (NS). Pathology examination of the specimen showed R0 resection in all patients with malignant PNT. The mean time to resumption of previous activities for patients undergoing Lap DP or Lap En was 3 weeks. There were no postoperative (30 days) or hospital deaths.

Conclusions This series demonstrates that LPS is feasible and safe in benign-appearing and malignant neuroendocrine pancreatic tumors (NEPTs). The benefits of minimally invasive surgery were manifest in the short hospital stay and acceptable pancreas-related complications in high-risk patients. LPS can achieve negative tangential margins in a high percentage of patients with malignant tumors. Although surgical cure is rare in malignant NEPTs, significant long-term palliation can be achieved in a large proportion of patients with an aggressive surgical approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Stephen AE, Hodin RA (2006) Neuroendocrine tumors of the pancreas, excluding gastrinoma. Surg Oncol Clin N Am 15:497–510

    Article  PubMed  Google Scholar 

  2. Touzios JG, Kiely JM, Pitt SC et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241:776–785

    Article  PubMed  Google Scholar 

  3. Sarmiento JM, Que FG, Grant CS et al (2002) Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 132:976–982

    Article  PubMed  Google Scholar 

  4. Bartsch DK, Langer P, Wild A et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery and surveillance. Surgery 128:958–966

    Article  PubMed  CAS  Google Scholar 

  5. Demeure M, Klonoff D, Karam J et al (1991) Insulinomas associated with multiple endocrine neoplasia type 1: the needs for a different surgical approach. Surgery 110:998–1005

    PubMed  CAS  Google Scholar 

  6. Cadiot G, Vuagnat A, Doukhan I et al (1999) Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Gastroenterology 116:286–293

    Article  PubMed  CAS  Google Scholar 

  7. Gagner M, Pomp A (1994) Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc 8:408–410

    Article  PubMed  CAS  Google Scholar 

  8. Cushieri A (1994) Laparoscopic surgery of the pancreas. J R Coll Surg Edinb 39:187–194

    Google Scholar 

  9. Gagner M, Pomp A, Herrera MF (1996) Early experience with laparoscopic resection of islet cell tumors. Surgery 120:1051–1054

    Article  PubMed  CAS  Google Scholar 

  10. Assalia A, Gagner M (2004) Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. World J Surg 28:1239–1247

    Article  PubMed  Google Scholar 

  11. Mabrut JY, Fernández-Cruz L, Azagra JS et al (2005) Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 137:597–605

    Article  PubMed  Google Scholar 

  12. Patterson EJ, Gagner M, Salky B et al (2001) Laparoscopic pancreatic resection: single-institution experience with 19 patients. J Am Coll Surg 193:281–287

    Article  PubMed  CAS  Google Scholar 

  13. Kloppel G, Perren A, Hertz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci 1014:13–27

    Article  PubMed  Google Scholar 

  14. Kimura W, Inone T, Futawake N et al (1996) Spleen preserving distal pancreatectomy with conservation of the splenic artery and vein. Surgery 120:885–890

    Article  PubMed  CAS  Google Scholar 

  15. Warshaw L (1998) Conservation of the spleen with distal pancreatectomy. Arch Surg 123:550–553

    Google Scholar 

  16. Fernández-Cruz L, Martinez I, Gilabert R et al (2004) Laparoscopic distal pancreatectomy combined with preservation of the spleen for cystic neoplasms of the pancreas. J Gastrointest Surg 8:493–501

    Article  PubMed  Google Scholar 

  17. Fernández-Cruz L (2006) Distal pancreatic resection: technical differences between open and laparoscopic approaches. HPB 8:49–56

    PubMed  Google Scholar 

  18. Strasberg SM, Drebin JA, Linehan D (2003) Radical antegrade modular pancreatosplenectomy. Surgery 133:521–527

    Article  PubMed  Google Scholar 

  19. Fernández-Cruz L, Cosa R, Blanco L et al (2007) Curative laparoscopic resection for pancreatic neoplasms: A critical analisis from a single institution. J Gastrointest Surg 11:1607–1622

    Article  PubMed  Google Scholar 

  20. Fernández-Cruz L, Martinez I, Cesar-Borges G et al (2005) Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1. J Gastrointest Surg 9:381–388

    Article  PubMed  Google Scholar 

  21. Fernández-Cruz L, César-Borges G (2006) Laparoscopic strategies for resection of insulinoma. J Gastrointest Surg 10:752–760

    Article  PubMed  Google Scholar 

  22. Fernández-Cruz L, Sáenz A, Astudillo E et al (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 26:1057–1065

    Article  PubMed  Google Scholar 

  23. Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13

    Article  PubMed  Google Scholar 

  24. Bartsch DK, Schilling T, Ramaswamy A et al (2000) Management of nonfunctioning islet cell carcinomas. World J Surg 24:1418–1424

    Article  PubMed  CAS  Google Scholar 

  25. Kouvaraki MA, Solorzano CC, Saphiro SE et al (2005) Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89:170–185

    Article  PubMed  Google Scholar 

  26. Kazanjiam KK, Reber HA, Hines OJ (2006) Resection of pancreatic neuroendocrine tumors. Arch Surg 141:765–770

    Article  Google Scholar 

  27. Salorzano CC, Lee JE, Pisters PW et al (2001) Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 130:1078–1085

    Article  Google Scholar 

  28. Phan GQ, Yeo CJ, Hruban RH et al (1998) Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J. Gastrointest Surg 2:472–482

    Article  PubMed  CAS  Google Scholar 

  29. House MG, Cameron JL, Lillemoe KD et al (2006) Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastrointest Surg 10:138–145

    Article  PubMed  Google Scholar 

  30. Schurr PG, Strate T, Rese K et al (2007) Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg 245:273–281

    Article  PubMed  Google Scholar 

  31. Fendrich V, Langer P, Celiki I et al (2006) An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 244:845–853

    Article  PubMed  Google Scholar 

  32. Dralle H, Krohn SL, Karges W et al (2004) Surgery of resectable non-functioning neuroendocrine pancreatic tumors. World J Surg 28:1248–1260

    Article  PubMed  Google Scholar 

  33. Chung JC, Choi DW, Jo SH et al (2007) Malignant non-functioning endocrine tumors of the pancreas: predictive factors for survival after surgical treatment. World J Surg 31:579–585

    Article  PubMed  Google Scholar 

  34. Libutti SK, Alexander HR Jr (2006) Gastrinoma: sporadic and familial disease. Surg Oncol Clin N Am 15:479–496

    Article  PubMed  Google Scholar 

  35. Kisker O, Bastian D, Bartsch D et al (1998) Localization, malignant potential and surgical management of gastrinomas. World J Surg 22:651–658

    Article  PubMed  CAS  Google Scholar 

  36. Roy PK, Venzon DJ, Shojamanesh H et al (2000) Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine (Baltimore) 79:379–411

    Article  CAS  Google Scholar 

  37. Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635–644

    Article  PubMed  CAS  Google Scholar 

  38. Norton JA, Jensen RT (2004) Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 240:757–773

    Article  PubMed  Google Scholar 

  39. Norton JA, Alexander HR, Fraker DL et al (2003) Possibly primary lymph node gastrinomas: occurrence, natural history and predictive factors; a prospective study. Ann Surg 237:650–659

    Article  PubMed  Google Scholar 

  40. Smith SL, Branton SA, Avino AJ et al (1998) Vasoactive intestinal polypeptide secreting islet cell tumors; a 15-year experience and review of the literature. Surgery 124:1050–1055

    Article  PubMed  CAS  Google Scholar 

  41. Olausson M, Friman S, Herlenius G et al (2007) Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 13:327–333

    Article  PubMed  Google Scholar 

  42. Florman S, Toure B, Kim L et al (2004) Liver transplantation for neuroendocrine tumor. J Gastrointest Surg 8:208–212

    Article  PubMed  Google Scholar 

  43. Wermers RA, Fatonrechi V, Wynne AG et al (1996) The glucagonoma syndrome: clinical and pathological features in 21 patients. Medicine 75:53–63

    Article  PubMed  CAS  Google Scholar 

  44. Weinel RJ, Neuhaus C, Stapp J et al (1993) Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy. Ann Surg 218:640–645

    Article  PubMed  CAS  Google Scholar 

  45. Kirshbom PM, Kherai AR, Onaitis MW et al (1999) Foregut carcinoids: a clinical and biochemical analysis. Surgery 126:1105–1110

    Article  PubMed  CAS  Google Scholar 

  46. Maurer CA, Baer H-U, Dyong TH et al (1996) Carcinoid of the pancreas: clinical characteristics and morphological features. Eur J Cancer 32:1109–1116

    Article  Google Scholar 

  47. Norton JA (1994) Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 55(Suppl 3):98–103

    Article  PubMed  Google Scholar 

  48. Norton JA, Well SA Jr (1994) The surgical management of patients with multiple endocrine neoplasia type I. World J Surg 18:488–494

    Article  Google Scholar 

  49. O’Riordan D, O’Brien M, van Heerden JA et al (1994) Surgical management of insulinomas associated with múltiple endocrine neoplasia type I. World J Surg 8:488–494

    Article  Google Scholar 

  50. Thompson NW (1998) Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Oncol Clin N Am 7:881–891

    PubMed  CAS  Google Scholar 

  51. Doherty GM, Thompson NW (2003) Multiple endocrine neoplasia type 1: duodenopancreatic tumors. J Intern Med 253:590–598

    Article  PubMed  CAS  Google Scholar 

  52. Skogseid B, Eviksson B, Lundquist G et al (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73:281–289

    Article  PubMed  CAS  Google Scholar 

  53. Äkerstrom G, Hessman O, Skogreid B (2002) Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN-1. Langenbecks Arch Surg 386:558–569

    Article  PubMed  Google Scholar 

  54. Bartsch DK, Fendrich V, Langer P et al (2005) Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type-1. Ann Surg 242:757–766

    Article  PubMed  Google Scholar 

  55. Äkerstrom G, Hellman P, Skogseid B (2005) Pancreatic tumors as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol 19:819–830

    Article  PubMed  CAS  Google Scholar 

  56. Zogakis TG, Gibril F, Libutti SK et al (2003) Management and outcome of patients with sporadic gastrinoma arising in the duodenum. Ann Surg 238:42–48

    Article  PubMed  Google Scholar 

  57. Jensen RT (1998) Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243:477–488

    Article  PubMed  CAS  Google Scholar 

  58. Danforth DN Jr, Gorden P, Brennan MF (1984) Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 96:1027–1037

    PubMed  Google Scholar 

  59. Starke A, Saddig C, Manfeld L et al (2005) Malignant metastatic insulinoma: postoperative treatment and follow-up. World J Surg 29:789–793

    Article  PubMed  Google Scholar 

  60. Hirshberg B, Cochran C, Skarulis M et al (2005) Malignant insulinoma. Cancer 104:264–272

    Article  PubMed  Google Scholar 

  61. Tucker ON, Crotty PL, Conlon KC (2006) The management of insulinoma. Br J Surg 93:264–265

    Article  PubMed  CAS  Google Scholar 

  62. Thoeni RF, Mueller-Lisse UG, Chan R et al (2000) Detection of small functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 212:483–490

    Google Scholar 

  63. Grant CS (1998) Insulinoma. Surg Oncol Clin N Am 7:819–844

    PubMed  CAS  Google Scholar 

  64. Berends FJ, Cuesta MA, Kazemier G et al (2000) Laparoscopic detection and resection of insulinomas. Surgery 128:386–390

    Article  PubMed  CAS  Google Scholar 

  65. Gramatica L, Herrera MF, Mercado-Luna A et al (2002) Video-laparoscopic resection of insulinomas. World J Surg 26:1297–1300

    Article  PubMed  Google Scholar 

  66. Ihiara M, Obara T (2002) Minimally invasive endocrine surgery: laparoscopic resection of insulinomas. Biomed Pharmacother 56:227–230

    Article  Google Scholar 

  67. Ayav A, Bresler L, Brunand L et al (2005) Laparoscopic approach for insulinoma: a multicenter study. Langenbecks Arch Surg 390:134–140

    Article  PubMed  CAS  Google Scholar 

  68. Toniato A, Meduri F, Foletts M et al (2006) Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas. World J Surg 30:1916–1919

    Article  PubMed  Google Scholar 

  69. Jaroszewski D, Schlinkert RT, Thompson GB et al (2004) Laparoscopic localization and resection of insulinomas. Arch Surg 139:270–274

    Article  PubMed  Google Scholar 

  70. Sa Cunha A, Beau C, Rault A et al (2007) Laparoscopic versus open approach for solitary insulinoma. Surg Endosc 21:103–108

    Article  PubMed  Google Scholar 

  71. Lo CY, Lo CM, Fan SM (2000) Role of laparoscopic ultrasonography in intraoperative localization of pancreatic insulionoma. Surg Endosc 14:1131–1135

    Article  PubMed  CAS  Google Scholar 

  72. Rothmund M, Angelini L, Brunt LM et al (1990) Surgery for benign insulinoma: an international review. World J Surg 14:393–398

    Article  PubMed  CAS  Google Scholar 

  73. Hellman P, Goretzki P, Simon D et al (2000) Therapeutic experience of 65 cases with organic hyperinsulinism. Langenbecks Arch Surg 385:329–336

    Article  PubMed  CAS  Google Scholar 

  74. Park BJ, Alexander HR, Libatti SK et al (1998) Operative management of islet cell tumor arising in the head of the pancreas. Surgery 124:1056–1061

    Article  PubMed  CAS  Google Scholar 

  75. Knaebel HP, Diener MK, Wente MN et al (2005) Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg 92:539–546

    Article  PubMed  CAS  Google Scholar 

  76. Velanovich V (2006) Case-control comparison of laparoscopic versus open distal pancreatectomy. J Gastrointest Surg 10:95–98

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Tom Gorey, Professor of Surgery, Dublin (Ireland), for article preparation.

Author information

Authors and Affiliations

  1. Surgical Department, ICMD Hospital Clínic de Barcelona, University of Barcelona, Villarroel 170, Escalera 6, 4th Floor, 08036, Barcelona, Spain

    Laureano Fernández-Cruz, Laia Blanco, Rebeca Cosa & Héctor Rendón

Authors
  1. Laureano Fernández-Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laia Blanco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebeca Cosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Héctor Rendón
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laureano Fernández-Cruz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernández-Cruz, L., Blanco, L., Cosa, R. et al. Is Laparoscopic Resection Adequate in Patients with Neuroendocrine Pancreatic Tumors?. World J Surg 32, 904–917 (2008). https://doi.org/10.1007/s00268-008-9467-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-008-9467-2

Keywords

Search

Navigation